Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.

Total
0
Shares
Related Posts
Read More

Jim Cramer: This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

Jim Cramer likes Enbridge Inc. (NYSE: ENB), says Lazard, Inc. (NYSE: LAZ) is a good buy, and Advanced Drainage Systems, Inc. (NYSE: WMS) is an incredible infrastructure play. He also mentions Jacobs Solutions Inc. (NYSE: J) and Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Petrobras CEO was fired by Brazil's President, and Palantir Technologies Inc. (NYSE: PLTR) reported a 21% increase in first-quarter revenue.

ASTS